ECSP055821A - Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación - Google Patents

Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación

Info

Publication number
ECSP055821A
ECSP055821A EC2005005821A ECSP055821A ECSP055821A EC SP055821 A ECSP055821 A EC SP055821A EC 2005005821 A EC2005005821 A EC 2005005821A EC SP055821 A ECSP055821 A EC SP055821A EC SP055821 A ECSP055821 A EC SP055821A
Authority
EC
Ecuador
Prior art keywords
tiotropy
formulation containing
containing inhalation
pulverulent formulation
new
Prior art date
Application number
EC2005005821A
Other languages
English (en)
Inventor
Michael Trunk
Mareke Hartig
Michael Walz
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP055821(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP055821A publication Critical patent/ECSP055821A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

El invento se refiere a formulaciones pulverulentas que contienen tiotropio para la inhalación, a procedimientos para su producción, así como a su utilización para la preparación de un medicamento destinado al tratamiento de enfermedades de las vías respiratorias, en particular para el tratamiento de la COPD (chronic obstructive pulmonary disease = enfermedad pulmonar obstructiva crónica) y del asma.
EC2005005821A 2002-11-28 2005-05-26 Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación ECSP055821A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation

Publications (1)

Publication Number Publication Date
ECSP055821A true ECSP055821A (es) 2005-08-11

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005821A ECSP055821A (es) 2002-11-28 2005-05-26 Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación

Country Status (33)

Country Link
EP (1) EP1567135B1 (es)
JP (1) JP4977321B2 (es)
KR (1) KR101066805B1 (es)
CN (1) CN100574751C (es)
AR (1) AR042242A1 (es)
AT (1) ATE401861T1 (es)
AU (1) AU2003294714B2 (es)
BR (1) BR0316343A (es)
CA (1) CA2507579C (es)
CO (1) CO5580736A2 (es)
CY (1) CY1108420T1 (es)
DE (2) DE10255387A1 (es)
DK (1) DK1567135T3 (es)
EA (1) EA011549B1 (es)
EC (1) ECSP055821A (es)
ES (1) ES2310681T3 (es)
HR (1) HRP20050468A2 (es)
IL (1) IL168810A (es)
ME (1) MEP51608A (es)
MX (1) MXPA05005485A (es)
MY (1) MY140890A (es)
NO (1) NO20053090L (es)
PE (1) PE20040848A1 (es)
PL (1) PL376229A1 (es)
PT (1) PT1567135E (es)
RS (1) RS20050400A (es)
SA (1) SA04240467B1 (es)
SI (1) SI1567135T1 (es)
TW (1) TWI332837B (es)
UA (1) UA81930C2 (es)
UY (1) UY28096A1 (es)
WO (1) WO2004047796A2 (es)
ZA (1) ZA200502859B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
NO2600830T3 (es) * 2010-08-03 2018-07-21
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
CA2347856C (en) * 1998-11-13 2009-02-17 Jagotec Ag Dry powder for inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
IL149984A0 (en) * 2000-10-12 2002-12-01 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
ATE339951T1 (de) * 2002-04-04 2006-10-15 Boehringer Ingelheim Pharma Pulverzubereitungen zur inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
HRP20050468A2 (en) 2006-07-31
WO2004047796A3 (de) 2004-09-30
DE10255387A1 (de) 2004-06-09
MY140890A (en) 2010-01-29
HK1085918A1 (zh) 2006-09-08
BR0316343A (pt) 2005-09-27
ATE401861T1 (de) 2008-08-15
PT1567135E (pt) 2008-09-01
AU2003294714A1 (en) 2004-06-18
AR042242A1 (es) 2005-06-15
KR20050086887A (ko) 2005-08-30
CN100574751C (zh) 2009-12-30
MEP51608A (en) 2011-02-10
CN1717225A (zh) 2006-01-04
TW200500066A (en) 2005-01-01
EP1567135B1 (de) 2008-07-23
JP4977321B2 (ja) 2012-07-18
ZA200502859B (en) 2006-02-22
TWI332837B (en) 2010-11-11
SA04240467B1 (ar) 2008-10-15
CA2507579A1 (en) 2004-06-10
EA011549B1 (ru) 2009-04-28
NO20053090D0 (no) 2005-06-23
PL376229A1 (en) 2005-12-27
EA200500864A1 (ru) 2006-02-24
CY1108420T1 (el) 2014-04-09
AU2003294714B2 (en) 2009-10-08
NO20053090L (no) 2005-06-23
JP2006510622A (ja) 2006-03-30
RS20050400A (sr) 2007-04-10
CA2507579C (en) 2011-07-19
KR101066805B1 (ko) 2011-09-22
DK1567135T3 (da) 2008-10-27
UA81930C2 (uk) 2008-02-25
IL168810A (en) 2015-02-26
EP1567135A2 (de) 2005-08-31
PE20040848A1 (es) 2005-01-14
ES2310681T3 (es) 2009-01-16
SI1567135T1 (sl) 2008-10-31
DE50310208D1 (de) 2008-09-04
UY28096A1 (es) 2004-06-30
MXPA05005485A (es) 2005-07-25
CO5580736A2 (es) 2005-11-30
WO2004047796A2 (de) 2004-06-10

Similar Documents

Publication Publication Date Title
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
UY31235A1 (es) Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
HRP20050570A2 (en) Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate
HRP20040752B1 (hr) Superfina formulacija formoterola
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
CY1114157T1 (el) Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
UY29506A1 (es) Nuevas formas cristalinas de bromuro de tiotropio
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
PH12017502087A1 (en) Tiotropium inhalation solution for nebulization
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
ECSP066545A (es) Procedimiento para la preparación de sales de tiotropio, sales de tiotropio, así como formulaciones medicamentosas que las contienen
ECSP066543A (es) Nuevo anhidrato cristalino con accion anticolinergica
ECSP055821A (es) Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
UY30934A1 (es) Producto farmacéutico combinacion de un antagonista del receptor de quimioquina 1 (ccr1) y un antagonista muscarinico, composiciones farmacéuticas y aplicaciones.
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
WO2019098969A3 (en) Dry powder compositions for inhalation
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
BRPI0415685A (pt) sais de tiotrópio, processos para sua produção, bem como formulações de medicamentos contendo os mesmos